On Cavuto today, he was talking to an analyst who related a story from a CEO conference at Yale, where the CEO of a medical device manufacturer with a radioactive “seed” implanted in the prostrate would save surgery. But, under ZerOcare, medical devices are less remunerative than surgery where the doctors get paid more.
Fortunately, Widen, as a member of Congress, is exempt from ZerOcare. He will, probably, serve out his six years. That, and most people with prostate cancer die of old age.
“....with a radioactive “seed” implanted in the prostrate would save surgery.”
That procedure, or a similar one (radioactive implant) did not save my uncle’s life.
But overall, the treatment success rate for prostrate cancer is good.